The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes

Clinical Autonomic Research

Volumn 11, Issue 6, 2001, Pages 351-355

  Braune, Stefan ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Autonomic nervous system; MIBG; Multiple system atrophy; Parkinson disease

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; ADRENALIN; AMIODARONE; AMITRIPTYLINE; CLOMIPRAMINE; DESIPRAMINE; DIGOXIN; DILTIAZEM; DOXEPIN; EPHEDRINE; IMIPRAMINE; ISOPRENALINE; ISRADIPINE; LABETALOL; LOFEPRAMINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NICARDIPINE; NIFEDIPINE; NIMODIPINE; NORADRENALIN; NORTRIPTYLINE; PHENYLEPHRINE; RESERPINE; SALBUTAMOL; THREO 3,4 DIHYDROXYPHENYLSERINE; TRAMAZOLINE; TRIMIPRAMINE; UNINDEXED DRUG; VERAPAMIL; XYLOMETAZOLINE;

DIAGNOSTIC VALUE; HEART INNERVATION; HEART SCINTISCANNING; HUMAN; PARKINSON DISEASE; QUANTITATIVE DIAGNOSIS; RADIOISOTOPE DISTRIBUTION; REVIEW; SHY DRAGER SYNDROME; SYMPATHETIC INNERVATION;

EID: 0035736765     PISSN: 09599851     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02292766     Document Type: Review

References (39)

1. Imaging the primate adrenal medulla with 1231 and 1311 meta-iodobenzylguanidine
2. A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG)
3. Radioiodinated metaiodobenzylguanidine: A review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry
4. Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters
5. Sodium dependency of uptake of norepinephrine and m-iodobenzylguanidine into cultured human pheochromocytoma cells: Evidence of uptake-one
6. Adrenal medulla imaging agents: A structure-distribution relationship study of radiolabeled aralkylguanidines
7. Uptake of metaiodobenzylguanidine by bovine chromaffin granule membranes
8. Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function
9. Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man
10. Comparison of the secretory mechanisms of meta-iodobenzylguanidine (MIBG) and norepinephrine (NE) from the cultured bovine adrenomedullary cells
11. Scintigraphic detection of regional disruption of adrenergic neurons in the heart
12. Scintigraphic assessment of regional cardiac adrenergic innervation
13. 123I-MIBG uptake by the heart in Parkinson's disease: Assessment of cardiac denervation and diagnostic value
14. Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine 123 metaiodobenzyl-guanidine myocardial scintigraphy
15. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific
16. Decreased myocardial 123I-MIBG uptake in Parkinson's disease
17. L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: A multi-national, multi-centre dose ranging study in multiple system atrophy (MSA) and pure autonomic failure (PAF)
18. Cardiac uptake of [123I]MIBG separates PD from multiple system atrophy
19. Radiolabelled metaiodobenzylguanidine in assessment of autonomic dysfunction
20. 123I-MIBG myocardial scintigraphical analysis in patients with and without autonomic disorder
21. Metaiodobenzylguanidine imaging in diabetes mellitus: Assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia
22. Myocardial m-[123I]iodobenzylguanidine scintigraphy for the assessment of adrenergic cardiac innervation in patients with IDDM: Comparison with cardiovascular reflex tests and relationship to left ventricular function
23. Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy
24. Adrenergic supersensitivity in parkinsonians with orthostatic hypotension
25. Impaired cardiac uptake of meta-[123I]iodobenzylguanidine in Parkinson's disease with autonomic failure
26. 123I-MIBG uptake
27. Cardiac sympathetic denervation in Parkinson disease
28. Cardiac sympathetic denervation from the early stage of Parkinson's disease: Clinical and experimental studies with radiolabeled MIBG
29. Lewy bodies in the visceral autonomic nervous system in Parkinson's disease
30. Parkinson's disease: The distribution of Lewy bodies in the peripheral autonomic nervous system
31. Sympathetic cardioneuropathy in dysautonomias
32. Differentiating Parkinson's disease from multiple system atrophy by measuring cardiac iodine-123 metaiodobenzylguanidine accumulation
33. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease
34. 123I]MIBG separates Parkinson's disease from multiple system atrophy
35. Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT
36. Morphological and functional imaging studies on the diagnosis and progression of Parkinson's disease
37. Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease
38. Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET
39. Myocardial meta-[123I] iodobenzylguanidine (MIBG) uptake is different in Parkinson's disease and multiple system atrophy with autonomic failure